Powered by

Tetra Bio-Pharma Enters into Binding Proposal with Quantum Pharma Inc.

Nov 20, 2018 - GlobeNewswire

ORLEANS, Ontario, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. ("Tetra" or "TBP"), (TSX VENTURE: TBP) (OTCQB: TBPMF), and Quantum Pharma Inc. ("Quantum") today announced the signing of a binding proposal (the "Proposal") for exclusive access to a Health Canada licensed facility (i.e., Drug Establishment License; DEL) that enables the company to produce cannabis and cannabinoid drug products for Tetra's and Panag Pharma's development activities including the ocular drug formulations...